Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat

Neuroscience

Volumn 252, Issue , 2013, Pages 253-261

  Broer S ^a   Zolkowska, D ^a   Gernert, M ^b   Rogawski, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Botulinum neurotoxin; Convection enhanced delivery; Epilepsy; Hippocampus; Pentylenetetrazol; Seizure

Indexed keywords

BOTULINUM TOXIN B; PENTETRAZOLE;

AGGRESSION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; CONVECTION ENHANCED DELIVERY; DENTATE GYRUS; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; HIPPOCAMPUS; HYPERKINESIA; INTRAHIPPOCAMPAL DRUG ADMINISTRATION; MALE; MYOCLONUS; NONHUMAN; PRIORITY JOURNAL; PROCONVULSANT ACTIVITY; RAT; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

ANALYSIS OF VARIANCE; ANOVA; BONT; BOTULINUM NEUROTOXIN; CED; CONVECTION-ENHANCED DELIVERY; EEG; ELECTROENCEPHALOGRAM; EPILEPSY; HIPPOCAMPUS; PEEK; PENTYLENETETRAZOL; POLYARYLETHERETHERKETONE; PTZ; SEIZURE; SNAP-25; SYNAPTOSOMAL-ASSOCIATED PROTEIN OF 25 KDA; U; UNIT; VAMP2; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2;

ANIMALS; BOTULINUM TOXINS; CONVECTION; CONVULSANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 84884156544     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.050     Document Type: Article

References (50)

1. Anderson A.E., Hrachovy R.A., Antalffy B.A., Armstrong D.L., Swann J.W. A chronic focal epilepsy with mossy fiber sprouting follows recurrent seizures induced by intrahippocampal tetanus toxin injection in infant rats. Neuroscience 1999, 92:73-82.
2. Antonucci F., Bozzi Y., Caleo M. Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy. Epilepsia 2009, 50:963-966.
3. Ashton A.C., Dolly J.O. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J Neurochem 1988, 50:1808-1816.
4. Bankstahl M., Bankstahl J.P., Bloms-Funke P., Löscher W. Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models. Neurotoxicology 2012, 33:127-137.
5. Benagiano V., Lorusso L., Flace P., Girolamo F., Rizzi A., Bosco L., Cagiano R., Nico B., Ribatti D., Ambrosi G. VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex. BMC Neurosci 2011, 12:118-127.
6. Bergey G.K., Bigalke H., Nelson P.G. Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. J Neurophysiol 1987, 57:121-131.
7. Bigalke H., Heller I., Bizzini B., Habermann E. Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol 1981, 316:244-251.
8. Bigalke H., Müller H., Dreyer F. Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure. Toxicon 1986, 24:1065-1074.
9. Bigalke H., Dressler D., Frevert J. Immunological properties of botulinum toxins. Manual of botulinum toxin therapy 2009, 23-28. Cambridge University Press, Cambridge, (Chapter 4). D. Truong, D. Dressler, M. Hallett (Eds.).
10. A-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus 2000, 10:305-324.
11. Bragina L., Candiracci C., Barbaresi P., Giovedì S., Benfenati F., Conti F. Heterogeneity of glutamatergic and GABAergic release machineries in cerebral cortex. Neuroscience 2007, 146:1829-1840.
12. Bragina L., Giovedì S., Barbaresi P., Benfenati F., Conti F. Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex: analysis of synaptogyrin, vesicle-associated membrane protein, and syntaxin. Neuroscience 2010, 165:934-943.
13. Brin M.F. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 1997, 6(Suppl.):S146-S168.
14. Bröer S., Backofen-Wehrhahn B., Bankstahl M., Gey L., Gernert M., Löscher W. Vigabatrin for focal drug delivery in epilepsy: bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model. Neurobiol Dis 2012, 46:362-376.
15. Caleo M., Schiavo G. Central effects of tetanus and botulinum neurotoxins. Toxicon 2009, 54:593-599.
16. 2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J Neurosci 1997, 17:7190-7202.
17. Collingridge G.L., Davies J. The in vitro inhibition of GABA release by tetanus toxin. Neuropharmacology 1982, 21:851-855.
18. Colom L.V., Nassif-Caudarella S., Dickson C.T., Smythe J.W., Bland B.H. In vivo intrahippocampal microinfusion of carbachol and bicuculline induces theta-like oscillations in the septally deafferented hippocampus. Hippocampus 1991, 1:381-390.
19. Costantin L., Bozzi Y., Richichi C., Viegi A., Antonucci F., Funicello M., Gobbi M., Mennini T., Rossetto O., Montecucco C., Maffei L., Vezzani A., Caleo M. Antiepileptic effects of botulinum neurotoxin E. J Neurosci 2005, 25:1943-1951.
20. Deshpande S.S., Sheridan R.E., Adler M. A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon 1995, 33:551-557.
21. Dickinson-Anson H., McGaugh J.L. Bicuculline administered into the amygdala after training blocks benzodiazepine-induced amnesia. Brain Res 1997, 752:197-202.
22. Dickinson-Anson H., Mesches M.H., Coleman K., McGaugh J.L. Bicuculline administered into the amygdala blocks benzodiazepine-induced amnesia. Behav Neural Biol 1993, 60:1-4.
23. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 2009, 85:142-149.
24. Garbelli R., Inverardi F., Medici V., Amadeo A., Verderio C., Matteoli M., Frassoni C. Heterogeneous expression of SNAP-25 in rat and human brain. J Comp Neurol 2008, 506:373-386.
25. Gasior M., Tang R., Rogawski M.A. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins A and B into the amygdala in rat. J Pharmacol Exp Ther 2013, 346:528-534.
26. Gean P.W., Chang F.C. Bursting discharges in disinhibited amygdala slices: the role of excitatory amino acid receptors. Neuropharmacology 1991, 30:797-802.
27. Humeau Y., Doussau F., Grant N.J., Poulain B. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochemie 2000, 82:427-446.
28. Jefferys J.G., Whittington M.A. Review of the role of inhibitory neurons in chronic epileptic foci induced by intracerebral tetanus toxin. Epilepsy Res 1996, 26:59-66.
29. Johnson E.A. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu Rev Microbiol 1999, 53:551-575.
30. Keller J.E., Cai F., Neale E.A. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 2004, 43:526-532.
31. Lebeda F.J., Adler M., Erickson K., Chushak Y. Onset dynamics of type A botulinum neurotoxin-induced paralysis. J Pharmacokinet Pharmacodyn 2008, 35:251-267.
32. Löscher W. Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans. Eur J Pharmacol 2009, 610:1-11.
33. Matteoli M., Pozzi D., Grumelli C., Condliffe S.B., Frassoni C., Harkany T., Verderio C. The synaptic split of SNAP-25: Different roles in glutamatergic and GABAergic neurons?. Neuroscience 2009, 158:223-230.
34. McMahon H.T., Foran P., Dolly J.O., Verhage M., Wiegant V.M., Nicholls D.G. Tetanus toxin and botulinum toxins type A and B inhibit glutamate, γ-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. J Biol Chem 1992, 267:21338-21343.
35. Mellanby J., George G., Robinson A., Thompson P. Epileptiform syndrome in rats produced by injecting tetanus toxin into the hippocampus. J Neurol Neurosurg Psychiatry 1977, 40:404-414.
36. Moser V.C., McCormick J.P., Creason J.P., Macphail R.C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam Appl Toxicol 1988, 11:189-206.
37. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier, Amsterdam. 6th ed.
38. Pollack G.M., Shen D.D. A timed intravenous pentylenetetrazol infusion seizure model for quantitating the anticonvulsant effect of valproic acid in the rat. J Pharmacol Methods 1985, 13:135-146.
39. Rattka M., Brandt C., Bankstahl M., Bröer S., Löscher W. Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats. Neuropharmacology 2011, 60:505-512.
40. Rattka M., Brandt C., Löscher W. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats. Epilepsy Res 2013, 103:135-152.
41. Rice A.C., Floyd C.L., Lyeth B.G., Hamm R.J., Delorenzo R.J. Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. Epilepsia 1998, 39:1148-1157.
42. Rogawski M.A. Convection-enhanced delivery in the treatment of epilepsy. Neurotherapeutics 2009, 6:344-351.
43. Rossetto O., Morbiato L., Caccin P., Rigoni M., Montecucco C. Presynaptic enzymatic neurotoxins. J Neurochem 2006, 97:1534-1545.
44. Scharfman H.E. The neurobiology of epilepsy. Curr Neurol Neurosci Rep 2007, 7:348-354.
45. Seiffert E., Dreier J.P., Ivens S., Bechmann I., Tomkins O., Heinemann U., Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004, 24:7829-7836.
46. Sierra-Paredes G., Sierra-Marcuño G. Microperfusion of picrotoxin in the hippocampus of chronic freely moving rats through microdialysis probes: a new method of induce partial and secondary generalized seizures. J Neurosci Methods 1996, 67:113-120.
47. Simpson L.L. Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004, 44:167-193.
48. Verderio C., Pozzi D., Pravettoni E., Inverardi F., Schenk U., Coco S., Proux-Gillardeaux V., Galli T., Rossetto O., Frassoni C., Matteoli M. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 2004, 41:599-610.
49. Verderio C., Grumelli C., Raiteri L., Coco S., Paluzzi S., Caccin P., Rossetto O., Bonanno G., Montecucco C., Matteoli M. Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 2007, 8:142-153.
50. Yin D., Forsayeth J., Bankiewicz K.S. Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods 2010, 187:46-51.